Programme

“Competition: the answer in times of austerity?”
9 am Registration & welcome coffee 
9.30 am Welcome and orientation to the overarching theme
Prof Dr Walter Van Dyck, Director Vlerick Healthcare Management Centre
9.40 am

Plenary keynotes:
Competition amongst healthcare providers: Insights from the European Commission 
Prof Dr Jan De Maeseneer, Director International Centre for Primary Health Care and Family Medicine at Ghent University & Chair Expert Panel on effective ways of investing in Health (EXPH) at European Commission 

THE IMPACT OF REGULATION AND COMPETITION ON PHARMACEUTICAL INNOVATION
Prof Dr Marisa Miraldo, Associate Professor in Health Economics at Imperial College London

10.30 am Coffee break
 

Track 1:
Competing for access

Track 2:
Competing for capital

Track 3:
Competing for patients

11.00 am  Introduction Introduction Introduction
11.15 am Session 1:
The role of price competition in improving access
Richard Bergström, Director General at EFPIA − European Federation of Pharmaceutical Industries and Associations
Session 1:
Demystification of the risk capital provider: what are global financing trends in the bio/life science market?
Jan De Kerpel, PhD, MBA − Executive Director at Kempen & Co
Session 1:
The quality of care and its impact on the competition between healthcare providers
Prof Dr Kris Vanhaecht, Assistant Professor Quality in Healthcare at KU Leuven
11.40 am Session 2:
Improving access to medicines by tilting the balance towards societal priority setting
Dr Chris Van Hul – Medical Expert at Onafhankelijke Ziekenfondsen
Session 2:
Lessons learned from a serial entrepreneur: critical success factors within the different growth stages
Dirk Reyn, MBA, CEO at eTheRNA Immunotherapies NV
Session 2:
The Santeon hospital network and value-based differentiation: Transparency and collaboration between non-competing hospitals
Leonique Niessen, General Director at Santeon Hospital Group
12.05 pm Q&A Q&A Q&A
12.30 pm Lunch
2 pm Introduction Introduction Introduction
2.15 pm Session 3:
Different perspectives on containing costs of medicines
Dr Raf Mertens, General Director at KCE − Belgian Health Care Knowledge Centre
Session 3:
Experience from the health start-up scene: how to build better businesses
Leo Exter, MBA, Partner at Advance.Healthcare

Session 3:
Hospitals and competition: a view from the NHS and its reforms
Prof Dr Carol Propper, CBE, FBA, Professor of Economics at Imperial College London

2.40 pm Session 4:
From cost to competitive value in diagnostics: the beMedTech view
Roel Meeusen, Marketing Director at Roche Diagnostics (representing beMedTech)
Session 4:
Moving from start-up to established grower: the Biocartis case through a strategic finance lens
Ewoud Welten, CFO at Biocartis
Session 4:
How does a growing level of clustering between doctors impact competition and networks?
Prof Dr Filip Dewallens, Professor of Hospital Governance and Law at KU Leuven & Universiteit Antwerpen, Managing Partner at Dewallens & Partners law firm
3.05 pm Q&A Q&A Q&A
3.30 pm Coffee break
4 pm Plenary debate:
Competition: the answer in times of austerity?
Moderated by Kathleen Cools, Journalist and host of current affairs programme Terzake
5.20 pm Wrap-up & grand closing
Prof Dr Leo Neels, Chairman of the Advisory Board, Vlerick Healthcare Management Centre
5.30 pm Networking drink

More info about the speakers Enrol now

Accreditations
& Rankings

Equis Association of MBAs AACSB Financial Times Economist Intelligence Unit